William G. Iacono

William G. Iacono

Auto-generated profile, based on publicly available information

William G. Iacono

Department of Psychology, University of Minnesota

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
JTJorim J. Tielbeek
Jorim J. Tielbeek
EUEmil Uffelmann
Emil Uffelmann
BWBenjamin S. Williams
Benjamin S. Williams
LCLucía Colodro Conde
Lucía Colodro Conde
ÉGÉloi Gagnon
Éloi Gagnon
DPDanielle Posthuma
Danielle Posthuma

29 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JSJonathan D. Schaefer
Jonathan D. Schaefer
NHNayla R. Hamdi
Nayla R. Hamdi
SMStephen M. Malone
Stephen M. Malone
SVScott Vrieze
Scott Vrieze
SWSylia Wilson
Sylia Wilson
WIWilliam G. Iacono
William G. Iacono
Observational studies have linked cannabis use to an array of negative outcomes, including psychiatric symptoms, cognitive impairment, and educational and occupational underachievement. These associations are particularly strong when cannabis use occurs in adolescence. Nevertheless, causality remains unclear. The purpose of the present study was thus to examine associations between prospectively assessed adolescent cannabis use and young-adult outcomes (psychiatric, cognitive, and socioeconomic) in three longitudinal studies of twins (n = 3,762). Twins reporting greater cumulative cannabis use in adolescence reported higher levels of psychopathology as well as poorer socioeconomic outcomes in young adulthood. However, cannabis use remained associated only with socioeconomic outcomes (i.e., educational attainment, occupational status, and income) in monozygotic-cotwin control analyses, which account fully for shared genetic and environmental confounding. Follow-up analyses examining associations between twin differences in adolescent cannabis use and longitudinal change in academic functioning during the middle- and high-school years provided a possible mechanism for these associations, indicating that greater cannabis use during this period was associated with decreases in grade point average and academic motivation as well as increases in academic problem behavior and school disciplinary problems. Our findings thus suggest that cannabis use in adolescence has potentially causal, deleterious effects on adolescent academic functioning and young-adult socioeconomic outcomes despite little evidence suggesting a strong, causal influence on adult mental health or cognitive ability. Significance A widely voiced concern regarding cannabis legalization in the United States is that cannabis is harmful to minors, affecting the developing brain to increase emotional and cognitive problems while impairing functioning. However, these associations may be due to confounding by common vulnerability factors that make some individuals more prone to both cannabis use and negative outcomes. We evaluate this possibility by conducting a series of cotwin control analyses in a sample that combines data from three longitudinal studies. Our findings provide little support for a strong, causal relationship between adolescent cannabis use and adult mental health or cognitive ability but do suggest that cannabis use may impair academic functioning during the secondary school years, with downstream effects on socioeconomic status.

25 March 2015 in Adoption Quarterly
Verified
Journal Article
Open access
EHEmma Hamilton
Emma Hamilton
DSDiana R. Samek
Diana R. Samek
MKMargaret Keyes
Margaret Keyes
MMMatthew K. McGue
Matthew K. McGue
WIWilliam G. Iacono
William G. Iacono
It has been argued that transracially adopted children have increased risk of problems related to self-esteem and ethnic identity development. We evaluated this hypothesis across four groups of transracial adoptees: Asian (n = 427), Latino (n = 28), Black (n = 6), mixed/other (n = 20), and same-race White adoptees (n = 126) from 357 adoptive families. No mean differences were found in adoptees’ ratings of affect about adoption or of curiosity about birth parents. Some differences were found in general identity development and adjustment. There were notable differences in communication about race/ethnicity across groups and between parent and child report.

12 October 2021 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
JSJonathan D. Schaefer
Jonathan D. Schaefer
SJSeon-Kyeong Jang
Seon-Kyeong Jang
DCD. Angus Clark
D. Angus Clark
JDJoseph D. Deak
Joseph D. Deak
BHBrian M. Hicks
Brian M. Hicks
SWSylia Wilson
Sylia Wilson
Background: Recent well-powered genome-wide association studies have enhanced prediction of substance use outcomes via polygenic scores (PGSs). Here, we test (1) whether these scores contribute to prediction over-and-above family history, (2) the extent to which PGS prediction reflects inherited genetic variation v. demography (population stratification and assortative mating) and indirect genetic effects of parents (genetic nurture), and (3) whether PGS prediction is mediated by behavioral disinhibition prior to substance use onset.Methods: PGSs for alcohol, cannabis, and nicotine use/use disorder were calculated for Minnesota Twin Family Study participants (N = 2483, 1565 monozygotic/918 dizygotic). Twins' parents were assessed for histories of substance use disorder. Twins were assessed for behavioral disinhibition at age 11 and substance use from ages 14 to 24. PGS prediction of substance use was examined using linear mixed-effects, within-twin pair, and structural equation models.Results: Nearly all PGS measures were associated with multiple types of substance use independently of family history. However, most within-pair PGS prediction estimates were substantially smaller than the corresponding between-pair estimates, suggesting that prediction is driven in part by demography and indirect genetic effects of parents. Path analyses indicated the effects of both PGSs and family history on substance use were mediated via disinhibition in preadolescence.Conclusions: PGSs capturing risk of substance use and use disorder can be combined with family history measures to augment prediction of substance use outcomes. Results highlight indirect sources of genetic associations and preadolescent elevations in behavioral disinhibition as two routes through which these scores may relate to substance use.

23 September 2021 in Journal of Abnormal Psychology
Verified
Journal Article
Closed access
JSJonathan D. Schaefer
Jonathan D. Schaefer
SJSeon-Kyeong Jang
Seon-Kyeong Jang
SVScott Vrieze
Scott Vrieze
WIWilliam G. Iacono
William G. Iacono
MMMatt McGue
Matt McGue
SWSylia Wilson
Sylia Wilson
Observational studies have repeatedly linked cannabis use and increased risk of psychosis. We sought to clarify whether this association reflects a causal effect of cannabis exposure or residual confounding. We analyzed data from two cohorts of twins who completed repeated, prospective measures of cannabis use (N = 1544) and cannabis use disorder symptoms (N = 1458) in adolescence and a dimensional measure of psychosis-proneness (the Personality Inventory for DSM–5 Psychoticism scale) in adulthood. Twins also provided molecular genetic data, which were used to estimate polygenic risk of schizophrenia. Both cumulative adolescent cannabis use and use disorder were associated with higher Psychoticism scores in adulthood. However, we found no evidence of an effect of cannabis on Psychoticism or any of its facets in co-twin control models that compared the greater-cannabis-using twin to the lesser-using co-twin. We also observed no evidence of a differential effect of cannabis on Psychoticism by polygenic risk of schizophrenia. Although cannabis use and disorder are consistently associated with increased risk of psychosis, the present results suggest this association is likely attributable to familial confounds rather than a causal effect of cannabis exposure. Efforts to reduce the prevalence and burden of psychotic illnesses thus may benefit from greater focus on other therapeutic targets.

28 January 2021 in Addiction
Verified
Journal Article
Closed access
PDF file
SMStephen M. Malone
Stephen M. Malone
SWSylia Wilson
Sylia Wilson
JBJessica L. Bair
Jessica L. Bair
MMMatt McGue
Matt McGue
WIWilliam G. Iacono
William G. Iacono